Zorvolex(dicofenac) for management of Osteoarthritis(joint disorder) from Iroko Pharma gets US FDA approval

Zorvolex(dicofenac) for management of Osteoarthritis(joint disorder) from Iroko Pharma gets US FDA approval.Zorvolex(diclofenac) is developed with proprietary SoluMatrix FINE PARTICLE TECHNOLOGY  in which diclofenac is in submicron particles form that are approximately 20 times smaller than original size.This reduction in particle size results in increased surface area which leads to faster dissolution , prompt effect.
According to Iroko Pharma, Zorvolex was developed keeping in line with recommendations from US FDA and others that NSAIDs be used in lowest effective dose for short possible duration with individual patient treatment goal.

Aspirin double use offer - New study

According to a new study Aspirin,a NSAID populary used as pain killer has another hidden use  of resolving Inflammation.The study published in PNAS suggests Aspirin along with prevention of pain causing compounds also triggers cyclooxygens to make trace amount of related compound 15-HETE,which can be converted by a second enzyme into lipoxin , which is known to reverse the inflammation.
Note:As you know,Aspirin inhibits the enzyme Cyclooxygenase which plays major role in production of prostaglandins , which cause arthritis, headache and many other ailments